Empirical treatment of neonatal sepsis: are the current guidelines adequate?

Archives of Disease in Childhood. Fetal and Neonatal Edition
B Muller-PebodyiCAP Group (Improving Antibiotic Prescribing in Primary Care)

Abstract

To use national laboratory surveillance data to determine whether pathogens responsible for neonatal bacteraemia were sensitive to nationally recommended antibiotic regimens. All reports of neonatal bacteraemia received by the Health Protection Agency's voluntary surveillance scheme in England and Wales from January 2006 until March 2008, were extracted from the database. Organisms were ranked by frequency, and proportions susceptible to antimicrobials recommended for empirical treatment of neonatal sepsis were determined. There were 1516 reports of bacteraemia for neonates <48 h old (early-onset) and 3482 reports for neonates 2-28 days old (late-onset). For early-onset bacteraemia, group B streptococcus (GBS) was the most frequent pathogen (31%) followed by coagulase-negative staphylococci (CoNS; 22%), non-pyogenic streptococci (9%) and Escherichia coli (9%). For late-onset bacteraemia, CoNS were isolated most frequently (45%), followed by Staphylococcus aureus (13%), Enterobacteriaceae (9%), E coli (7%) and GBS (7%). More than 94% of organisms (early-onset) were susceptible to regimens involving combinations of penicillin with either gentamicin or amoxicillin, amoxicillin combined with cefotaxime or cefotaxime monotherapy. Mo...Continue Reading

Citations

Oct 22, 2013·The Journal of Infection·Andi L Shane, Barbara J Stoll
Jul 13, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Theresa L LamagniElizabeth Sheridan
Jun 10, 2011·The Pediatric Infectious Disease Journal·Stefania VergnanoPaul T Health
Jun 27, 2012·Antimicrobial Agents and Chemotherapy·Helgi PadariIrja Lutsar
Sep 26, 2013·Journal of Tropical Pediatrics·Suresh RamasamyBetsy Mathai
Aug 2, 2013·Journal of Tropical Pediatrics·Margot AndersonPaul N Newton
Nov 16, 2013·European Journal of Pediatrics·Jon Widding FjalstadClaus Klingenberg
Apr 3, 2014·Therapeutic Drug Monitoring·Caroline Fonzo-ChristePascal Bonnabry
Feb 14, 2014·European Journal of Pediatrics·Irja LutsarUNKNOWN NeoMero Consortium
Dec 14, 2011·International Journal of Pediatrics·Sindhu SivanandanKamala Swarnam
Feb 10, 2012·International Journal of Pediatrics·Michela PaolucciVittorio Sambri
Jul 7, 2011·Current Infectious Disease Reports·Rajesh K AnejaJoseph A Carcillo
Apr 6, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M HeidekingR Berner
Nov 23, 2011·European Journal of Pediatrics·Basma ShoumanMona F Salama
Oct 14, 2011·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Alessandro BorghesiMauro Stronati
Oct 4, 2012·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Valentina PisaniMario De Curtis
Sep 14, 2012·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·C TziallaM Stronati
Jan 25, 2014·Expert Review of Anti-infective Therapy·Alison KentPaul T Heath
Dec 3, 2015·The Journal of Antimicrobial Chemotherapy·Julia A BielickiUNKNOWN Antibiotic Resistance and Prescribing in European Children project
Sep 30, 2015·Archives of Disease in Childhood·N SpyridisUNKNOWN ARPEC Project Group Members
Feb 22, 2012·Clinics in Perinatology·Nidhi TripathiP Brian Smith
Mar 10, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Chryssoula TziallaMauro Stronati
Jan 30, 2013·The Journal of Pharmacy and Pharmacology·Natalie J MedlicottRoland S Broadbent
Sep 6, 2013·Pediatrics International : Official Journal of the Japan Pediatric Society·Hilal OzkanMustafa Hacımustafaoglu
Jan 30, 2015·Archives of Disease in Childhood·Ifeanyichukwu O OkikePaul T Heath
Nov 27, 2014·Archives of Disease in Childhood. Fetal and Neonatal Edition·Ying Dong, Christian P Speer
Apr 29, 2015·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Alan P Johnson
Apr 19, 2015·Italian Journal of Pediatrics·Chryssoula TziallaGiovanni Corsello
Dec 23, 2014·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·Y Aujard
Jan 22, 2015·Journal of Tropical Pediatrics·Alonso Zea-Vera, Theresa J Ochoa
Nov 12, 2013·Scottish Medical Journal·S S KrishnamoorthyJ Sanderson
Jan 16, 2017·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Majeda S HammoudMoghis Ur Rehman
Jul 27, 2018·Clinical & Experimental Ophthalmology·Stephanie WatsonMonica M Lahra
Oct 28, 2017·Archives of Disease in Childhood. Fetal and Neonatal Edition·Benjamin CailesUNKNOWN neonIN network

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Archives of Disease in Childhood. Fetal and Neonatal Edition
Stefania VergnanoPaul T Heath
The Pediatric Infectious Disease Journal
M Cohen-WolkowiezP B Smith
Journal of Perinatology : Official Journal of the California Perinatal Association
Daniel K BenjaminR H Clark
Journal of Paediatrics and Child Health
S S MehrJ Carr
© 2021 Meta ULC. All rights reserved